Opportunistic Infections Citation List:
February 18 - March 3, 2011
OPPORTUNISTIC PROTOZOA COMPOUNDS (including pneumocystis, cryptosporidium, toxoplasma, microsporidia [encephalitozoon, enterocytozoon, vittaforma])
1. Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach. Kortagere, S., E. Mui, R. McLeod, and W.J. Welsh. Journal of Computer-Aided Molecular Design, 2011. [Epub ahead of print]; PMID[21359560].
[Pubmed]. OI_0218-030311.
ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
2. Design, synthesis and antifungal evaluation of 1-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-1H-1, 2,4-triazol-5(4H)-one. Jiang, Y., Y. Cao, J. Zhang, Y. Zou, X. Chai, H. Hu, Q. Zhao, Q. Wu, D. Zhang, and Q. Sun. European Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21354675].
[Pubmed]. OI_0218-030311.
3. Curcumin as a promising anticandidal of clinical interest. Neelofar, K., S. Shreaz, B. Rimple, S. Muralidhar, M. Nikhat, and L.A. Khan. Canadian Journal of Microbiology, 2011. 57(3): p. 204-210; PMID[21358761].
[Pubmed]. OI_0218-030311.
4. Chemoprevention by essential oil of turmeric leaves (Curcuma longa L.) on the growth of Aspergillus flavus and aflatoxin production. Sindhu, S., B. Chempakam, N.K. Leela, and R.S. Bhai. Food and Chemical Toxicology, 2011. [Epub ahead of print]; PMID[21354246].
[Pubmed]. OI_0218-030311.
5. Inhibition of Candida albicans biofilm formation and yeast-hyphal transition by 4-hydroxycordoin. Messier, C., F. Epifano, S. Genovese, and D. Grenier. Phytomedicine, 2011. [Epub ahead of print]; PMID[21353508].
[Pubmed]. OI_0218-030311.
6. Pyridine-derived thiosemicarbazones and their tin(IV) complexes with antifungal activity against Candida spp. Parrilha, G.L., J.G. da Silva, L.F. Gouveia, A.K. Gasparoto, R.P. Dias, W.R. Rocha, D.A. Santos, N.L. Speziali, and H. Beraldo. European Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21353348].
[Pubmed]. OI_0218-030311.
7. Surface-modified sulfur nanoparticles: an effective antifungal agent against Aspergillus niger and Fusarium oxysporum. Roy Choudhury, S., M. Ghosh, A. Mandal, D. Chakravorty, M. Pal, S. Pradhan, and A. Goswami. Applied Microbiology and Biotechnology, 2011. [Epub ahead of print]; PMID[21350853].
[Pubmed]. OI_0218-030311.
8. Activities of Triazole-Echinocandin Combinations against Candida Species in Biofilms and as Planktonic Cells. Chatzimoschou, A., A. Katragkou, M. Simitsopoulou, C. Antachopoulos, E. Georgiadou, T.J. Walsh, and E. Roilides. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21343465].
[Pubmed]. OI_0218-030311.
9. Chemical constituents of Talauma arcabucoana (Magnoliaceae): their brine shrimp lethality and antimicrobial activity. Corredor Barinas, J.A. and L.E. Cuca Suarez. Natural Product Research, 2011. [Epub ahead of print]: p. 1-8; PMID[21347974].
[Pubmed]. OI_0218-030311.
10. Milk Kefir: Ultrastructure, Antimicrobial Activity and Efficacy on Aflatoxin B1 Production by Aspergillus flavus. Ismaiel, A.A., M.F. Ghaly, and A.K. El-Naggar. Current Microbiology, 2011. [Epub ahead of print]; PMID[21350802].
[Pubmed]. OI_0218-030311.
11. Evaluation of antimicrobial effectiveness of C-8 xylitol monoester as an alternative preservative for cosmetic products. Amaral, L.F., N.S. Camilo, M.D. Pereda, C.E. Levy, P. Moriel, and P.G. Mazzola. International Journal of Cosmetic Science, 2011. [Epub ahead of print]; PMID[21338375].
[Pubmed]. OI_0218-030311.
12. Antifungal activity of essential oils and their synergy with fluconazole against drug-resistant strains of Aspergillus fumigatus and Trichophyton rubrum. Khan, M.S. and I. Ahmad. Applied Microbiology and Biotechnology, 2011. [Epub ahead of print]; PMID[21336686].
[Pubmed]. OI_0218-030311.
13. Chemical Constituents, Antimicrobial and Antimalarial Activities of Zanthoxylum monophyllum. Rodriguez-Guzman, R., L.C. Johansmann Fulks, M.M. Radwan, C.L. Burandt, and S.A. Ross. Planta Medica, 2011. [Epub ahead of print]; PMID[21341176].
[Pubmed]. OI_0218-030311.
14. Antifungal Activity of Xanthones: Evaluation of their Effect on Ergosterol Biosynthesis by High-performance Liquid Chromatography. Pinto, E., C. Afonso, S. Duarte, L. Vale-Silva, E. Costa, E. Sousa, and M. Pinto. Chemical Biology & Drug Design, 2011. 77(3): p. 212-222; PMID[21244637].
[Pubmed]. OI_0218-030311.
15. Short- and medium-chain fatty acids exhibit antimicrobial activity for oral microorganisms. Huang, C.B., Y. Altimova, T.M. Myers, and J.L. Ebersole. Archives of Oral Biology, 2011. [Epub ahead of print]; PMID[21333271].
[Pubmed]. OI_0218-030311.
16. Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus. Faria, N.C., J.H. Kim, L.A. Goncalves, M.D. Martins, K.L. Chan, and B.C. Campbell. Letters in Applied Microbiology, 2011. [Epub ahead of print]; PMID[21332761].
[Pubmed]. OI_0218-030311.
17. Anti-Candida effect of bacillomycin D-like lipopeptides from Bacillus subtilis B38. Tabbene, O., L. Kalai, I. Ben Slimene, I. Karkouch, S. Elkahoui, A. Gharbi, P. Cosette, M.L. Mangoni, T. Jouenne, and F. Limam. FEMS Microbiol Letters, 2011. 316(2): p. 108-114; PMID[21204933].
[Pubmed]. OI_0218-030311.
18. Interaction of a copper(II)-Schiff base complexes with calf thymus DNA and their antimicrobial activity. Sabolova, D., M. Kozurkova, T. Plichta, Z. Ondrusova, D. Hudecova, M. Simkovic, H. Paulikova, and A. Valent. International Journal of Biological Macromolecules, 2011. 48(2): p. 319-325; PMID[21145345].
[Pubmed]. OI_0218-030311.
19. Chitosan-EDTA New Combination is a Promising Candidate for Treatment of Bacterial and Fungal Infections. El-Sharif, A.A. and M.H. Hussain. Current Microbiology, 2011. 62(3): p. 739-745; PMID[20963418].
[Pubmed]. OI_0218-030311.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
20. Developing Pyrrole-Derived Antimycobacterial Agents: a Rational Lead Optimization Approach. Biava, M., G.C. Porretta, G. Poce, C. Battilocchio, S. Alfonso, A. de Logu, F. Manetti, and M. Botta. ChemMedChem, 2011. [Epub ahead of print]; PMID[21341373].
[Pubmed]. OI_0218-030311.
21. Synthesis and anti-mycobacterial activity of novel amino alcohol derivatives. Cunico, W., C.R. Gomes, M.L. Ferreira, T.G. Ferreira, D. Cardinot, M.V. de Souza, and M.C. Lourenco. European Journal of Medicinal Chemistry, 2011. 46(3): p. 974-978; PMID[21295888].
[Pubmed]. OI_0218-030311.
22. Anti-tubercular agents. Part 6: Synthesis and antimycobacterial activity of novel arylsulfonamido conjugated oxazolidinones. Kamal, A., R.V. Shetti, S. Azeeza, P. Swapna, M.N. Khan, I.A. Khan, S. Sharma, and S.T. Abdullah. European Journal of Medicinal Chemistry, 2011. 46(3): p. 893-900; PMID[21272965].
[Pubmed]. OI_0218-030311.
23. Synthesis and antitubercular activity of monocyclic nitroimidazoles: Insights from econazole. Lee, S.H., S. Kim, M.H. Yun, Y.S. Lee, S.N. Cho, T. Oh, and P. Kim. Bioorganic and Medicinal Chemistry Letters, 2011. 21(5): p. 1515-1518; PMID[21277200].
[Pubmed]. OI_0218-030311.
24. Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium. Sano, C., Y. Tatano, T. Shimizu, S. Yamabe, K. Sato, and H. Tomioka. International Journal of Antimicrobial Agents, 2011. [Epub ahead of print]; PMID[21353489].
[Pubmed]. OI_0218-030311.
Citations from the ISI Web of Knowledge Listings for O.I.
25. Galactomannan-amphotericin B conjugate: synthesis and biological activity. Farber, S., D. Ickowicz, E. Sionov, S. Kagan, I. Polacheck, and A.J. Domb. Polymers Advanced Technologies, 2010. Special Issue: p. 110-125; ISI[000285881800018].
[WOS]. OI_0218-030311.
26. Synthesis of Azole-containing Piperazine Derivatives and Evaluation of their Antibacterial, Antifungal and Cytotoxic Activities. Gan, L.L., B. Fang, and C.H. Zhou. Bulletin of the Korean Chemical Society, 2010. 31(12): p. 3684-3692; ISI[000286150900036].
[WOS]. OI_0218-030311.
27. Chemical Composition and Antimicrobial Activity of the Essential Oils from the Flower, Leaf, and Stem of Senecio pandurifolius. Kahriman, N., G. Tosun, S. Terzioglu, S.A. Karaoglu, and N. Yayli. Records of Natural Products, 2011. 5(2): p. 82-91; ISI[000286433900002].
[WOS]. OI_0218-030311.
28. Phytochemical screening and antimicrobial activities of Euphorbia balsamifera leaves, stems and root against some pathogenic microorganisms. Kamba, A.S. and L.G. Hassan. African Journal of Pharmacy and Pharmacology, 2010. 4(9): p. 645-652; ISI[000285688300005].
[WOS]. OI_0218-030311.
29. Silver Nanoparticles Effect on Antimicrobial and Antifungal Activity of New Heterocycles. Kandile, N.G., H.T. Zaky, M.I. Mohamed, and H.M. Mohamed. Bulletin of the Korean Chemical Society, 2010. 31(12): p. 3530-3538; ISI[000286150900010].
[WOS]. OI_0218-030311.
30. The Potential Inhibitory Effect of Cuminum Cyminum, Ziziphora Clinopodioides and Nigella Sativa Essential Oils on the Growth of Aspergillus Fumigatus and Aspergillus Flavus. Khosravi, A.R., M.H. Minooeianhaghighi, H. Shokri, S.A. Emami, S.M. Alavi, and J. Asili. Brazilian Journal of Microbiology, 2011. 42(1): p. 216-224; ISI[000286320600027].
[WOS]. OI_0218-030311.
31. Antimicrobial Activity Evaluation of Cassia spectabilis Leaf Extracts. Krishnan, N., S. Ramanathan, S. Sasidharan, V. Murugaiyah, and S.M. Mansor. International Journal of Pharmacology, 2010. 6(4): p. 510-514; ISI[000285675900028].
[WOS]. OI_0218-030311.
32. Extraction and characterization of chitin and chitosan from crustacean by-products: Biological and physicochemical properties. Limam, Z., S. Selmi, S. Sadok, and A. El Abed. African Journal of Biotechnology, 2011. 10(4): p. 640-647; ISI[000286526500024].
[WOS]. OI_0218-030311.
33. Biological Assays and Chemical Composition of Volatile Oils of Bupleurum fruticosum L. (Apiaceae). Maxia, A., M.A. Frau, B. Marongiu, A. Piras, S. Porcedda, D. Falconieri, M.J. Goncalves, C. Cavaleiro, and L. Salgueiro. Records of Natural Products, 2011. 5(2): p. 92-99; ISI[000286433900003].
[WOS]. OI_0218-030311.
34. Identification of 3-phenylaminoquinolinium and 3-phenylaminopyridinium salts as new agents against opportunistic fungal pathogens. Mazu, T.K., J.R. Etukala, X.Y. Zhu, M.R. Jacob, S.I. Khan, L.A. Walker, and S.Y. Ablordeppey. Bioorganic & Medicinal Chemistry, 2011. 19(1): p. 524-533; ISI[000285724800053].
[WOS]. OI_0218-030311.
35. Synthesis and Activity of Novel 1-Halogenobenzylindole Linked Triazole Derivatives as Antifungal Agents. Na, Y.M. Bulletin of the Korean Chemical Society, 2011. 32(1): p. 307-310; ISI[000286538600056].
[WOS]. OI_0218-030311.
36. Antimicrobial activity of Gunnera perpensa and Heteromorpha arborescens var. abyssinica. Nkomo, M. and L. Kambizi. Journal of Medicinal Plants Research, 2009. 3(12): p. 1051-1055; ISI[000281784800011].
[WOS]. OI_0218-030311.
37. Synthetic UDP-Furanoses as Potent Inhibitors of Mycobacterial Galactan Biogenesis. Peltier, P., M. Belanova, P. Dianiskova, R.K. Zhou, R.B. Zheng, J.A. Pearcey, M. Joe, P.J. Brennan, C. Nugier-Chauvin, V. Ferrieres, T.L. Lowary, R. Daniellou, and K. Mikusova. Chemistry & Biology, 2010. 17(12): p. 1356-1366; ISI[000287016000013].
[WOS]. OI_0218-030311.
38. Antimicrobial and free radical scavenging activity of extracts of some Indian medicinal plants. Salar, R.K. and A. Dhall. Journal of Medicinal Plants Research, 2010. 4(22): p. 2313-2320; ISI[000285690000002].
[WOS]. OI_0218-030311.
39. Efficacy of Origanum essential oils for inhibition of potentially pathogenic fungi. Souza, N.A.B., E.D. Lima, D.N. Guedes, F.D. Pereira, E.L. de Souza, and F.B. de Sousa. Brazilian Journal of Pharmaceutical Sciences, 2010. 46(3): p. 499-508; ISI[000286701000013].
[WOS]. OI_0218-030311.
40. Conventional as well as microwave assisted synthesis and antimicrobial screening of 4-aryl-3-chloro-1- (5-nitroindazol-1-yl) acetamido -2-oxo-azetidines. Upadhyay, A., S.K. Srivastava, S.D. Srivastava, and R. Yadav. Indian Journal of Chemistry Section B-Organic Chemistry Including Medicinal Chemistry, 2011. 50(1): p. 89-97; ISI[000286568600004].
[WOS]. OI_0218-030311.
41. Synthesis of Novel D-Glucose-derived Benzyl and Alkyl 1,2,3-Triazoles as Potential Antifungal and Antibacterial Agents. Wei, J.J., L. Jin, K. Wan, and C.H. Zhou. Bulletin of the Korean Chemical Society, 2011. 32(1): p. 229-238; ISI[000286538600043].
[WOS]. OI_0218-030311.
42. Antimicrobial screening of Terminalia avicennoides and Acalypha wilkesiana. Akpomie, O.O. and S. Olorungbon. African Journal of Biotechnology, 2011. 10(2): p. 180-182; ISI[000286148100010].
[WOS]. OI_0218-030311.